Xcout IntelSign inSubscribe

Oxford Nanopore Technologies

BiotechOxford, United Kingdom

Oxford Nanopore Technologies plc is a UK-based company which develops and sells nanopore sequencing products for the direct, electronic analysis of single molecules. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

Subscribe to see Oxford Nanopore Technologies’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Oxford Nanopore Technologies at a glance

Oxford Nanopore Technologies is a biotech company headquartered in Oxford, United Kingdom, founded in 2005. Xcout tracks 19 named people at Oxford Nanopore Technologies, including Vijay Manthripragada (President, CEO & Director).

Industry
Biotech
Headquarters
Oxford, United Kingdom
Founded
2005

Oxford Nanopore Technologies leadership

  • Vijay ManthripragadaPresident, CEO & Director
  • Francis Van ParysChief Executive Officer
  • James LawsChief Operating Officer
  • Allan Michael DicksChief Financial Officer
  • Nick KeherChief Financial Officer
  • Jose RevueltaChief Strategy Officer

13 more named people on record for Oxford Nanopore Technologies, with roles, board committees and tenure — see the full roster →

Oxford Nanopore Technologies competitors

A few of Oxford Nanopore Technologies's closest competitors — see the full list of competitors and alternatives →

10x Genomics, Inc.TXG · BiotechPleasanton, United States
66% matchPublic

Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company's offerings feature Chromium and Chromium Connect instruments, supported by indispensable items such as microfluidic chips, slides, and reagents. A significant portion of their portfolio focuses on single-cell solutions, leveraging their Chromium platforms. These allow for precise measurement of gene activity at the individual cell level (single cell gene expression), detailed assessment of immune cell function and their targets (single cell immune profiling), exploration of DNA's physical organization and epigenetic modifications (single cell Assay for Transposase Accessible Chromatin - ATAC), and the concurrent quantification of both genetic activity and epigenetic programming across tens of thousands of cells in a single experiment (single cell multiome ATAC + gene expression). Additionally, 10x Genomics offers the Visium spatial gene expression solution, which maps gene activity patterns within specific tissue sections and can also facilitate co-detection of gene expression and proteins when paired with immunofluorescence. Their varied customer base includes academic, governmental, biopharmaceutical, and biotechnology organizations, among others.

Market cap$9.5B
Employees1,306
10x Genomics, Inc. competitors & alternatives →

Get Oxford Nanopore Technologies's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Something wrong or missing about Oxford Nanopore Technologies? Suggest a correction

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Oxford Nanopore Technologies — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Oxford Nanopore Technologies in Xcout Intel

  • 19 named people with titles, LinkedIn and board committees
  • 1 corporate event with sources — deals, leadership changes, layoffs
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →